Active Ingredient: INDIGOTINDISULFONATE SODIUM
Proprietary Name: BLUDIGO
Dosage Form; Route of Administration: SOLUTION; INTRAVENOUS
Strength: 40MG/5ML (8MG/ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N216264
Product Number: 001
Approval Date: Jul 8, 2022
Applicant Holder Full Name: PROVEPHARM SAS
Marketing Status:
Prescription
Patent and Exclusivity Information
